NCT02857777View on ClinicalTrials.gov

Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 9, 2016

Primary Completion Date

January 27, 2017

Study Completion Date

January 27, 2017

Conditions

Healthy

Interventions

DRUG

Esketamine

Subjects will self-administer intranasal esketamine as per the treatment regimen.

Trial Locations (1)

Unknown

Cypress

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT02857777 - Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects | Biotech Hunter | Biotech Hunter